Page last updated: 2024-10-31

methiothepin and Dyskinesia, Medication-Induced

methiothepin has been researched along with Dyskinesia, Medication-Induced in 1 studies

Methiothepin: A serotonin receptor antagonist in the CENTRAL NERVOUS SYSTEM used as an antipsychotic.
methiothepin : A dibenzothiepine that is 10,11-dihydrodibenzo[b,f]thiepine bearing additional methylthio and 4-methylpiperazin-1-yl substituents at positions 8 and 10 respectively. Potent 5-HT2 antagonist, also active as 5-HT1 antagonist. Differentiates 5-HT1D sub-types. Also displays affinity for rodent 5-HT5B, 5-HT5A, 5-HT7 and 5-HT6 receptors (pK1 values are 6.6, 7.0, 8.4 and 8.7 respectively).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hutson, PH1
Bristow, LJ1
Cunningham, JR1
Hogg, JE1
Longmore, J1
Murray, F1
Pearce, D1
Razzaque, Z1
Saywell, K1
Tricklebank, MD1

Other Studies

1 other study available for methiothepin and Dyskinesia, Medication-Induced

ArticleYear
The effects of GR127935, a putative 5-HT1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HT concentration and behaviour in the guinea pig.
    Neuropharmacology, 1995, Volume: 34, Issue:4

    Topics: Animals; Biogenic Monoamines; Brain; Dyskinesia, Drug-Induced; Electric Stimulation; Fluoxetine; Gui

1995